Melatonin as a cardioprotective therapy following ST-segment elevation myocardial infarction: is it really promising? Reply

Hausenloy DJ, Garcia-Dorado D, Botker HE, Davidson SM, Downey J, Engel F, Jennings R, Lecour S, Leor J, Madonna R, Ovize M, Perrino C, Prunier F, Schulz R, Sluijter JPG, Van Laake LW, Vinten-Johansen J, Yellon DM, Ytrehus K, Heusch G, Ferdinandy P (2017)

Publication Type: Journal article, Letter

Publication year: 2017

Journal

Cardiovascular Research Oxford University Press

Book Volume: 113

Pages Range: 1418-1419

Journal Issue: 11

DOI: 10.1093/cvr/cvx137

Authors with CRIS profile

Felix Engel Professur für Experimentelle Nieren- und Kreislaufforschung

Involved external institutions

University College London (UCL) GB United Kingdom (GB)

How to cite

APA:

Hausenloy, D.J., Garcia-Dorado, D., Botker, H.E., Davidson, S.M., Downey, J., Engel, F.,... Ferdinandy, P. (2017). Melatonin as a cardioprotective therapy following ST-segment elevation myocardial infarction: is it really promising? Reply. Cardiovascular Research, 113(11), 1418-1419. https://doi.org/10.1093/cvr/cvx137

MLA:

Hausenloy, Derek J., et al. "Melatonin as a cardioprotective therapy following ST-segment elevation myocardial infarction: is it really promising? Reply." Cardiovascular Research 113.11 (2017): 1418-1419.

BibTeX: Download